XBI

SPDR S&P Biotech ETF

Up$86.59
+$1.81
(+2.13%)
As of 1:00:00 AM EDT | 2/15/19  |  Market Closed

XBI Trading Data

Open

$85.1

Low Price

$84.82

High Price

$86.59

Previous Last Price

$84.78

Bid Size

$0 X 0

Ask Size

$0 X 0

XBI Portfolio Data

AUM

$4,020,772,000

Shares

47,600

PE Ratio

17.32

Price / Book Ratio

4.4

Expense Ratio

0.35

Net Asset Value

$84.47

Volume

Volume

3,959,100

Avg. Volume (YDT)

4,627,259

Dollar Volume

$312,529,205

Weekly Avg. Volume

3,065,740

Monthly Avg. Volume

3,953,765

Quarterly Avg. Volume

5,758,353

XBI Fund Description

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

XBI Chart

XBI Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Biotech ETF

Inception Date

2006-01-31

Asset Class

Equity

Asset Class Size

Biotech

XBI Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XBI Holdings

Top 10 Holdings

Mirati Therapeutics Inc. (MRTX)
2.02%
SAGE Therapeutics Inc. (SAGE)
1.93%
Portola Pharmaceuticals Inc. (PTLA)
1.89%
Array BioPharma Inc. (ARRY)
1.72%
Celgene Corporation (CELG)
1.65%
FibroGen Inc. (FGEN)
1.62%
bluebird bio Inc. (BLUE)
1.62%
Exact Sciences Corporation (EXAS)
1.61%
Incyte Corporation (INCY)
1.57%
ACADIA Pharmaceuticals Inc. (ACAD)
1.54%

Total XBI Holdings

Total Holdings: 122

Mirati Therapeutics Inc. (MRTX)
2.02%
SAGE Therapeutics Inc. (SAGE)
1.93%
Portola Pharmaceuticals Inc. (PTLA)
1.89%
Array BioPharma Inc. (ARRY)
1.72%
Celgene Corporation (CELG)
1.65%
FibroGen Inc. (FGEN)
1.62%
bluebird bio Inc. (BLUE)
1.62%
Exact Sciences Corporation (EXAS)
1.61%
Incyte Corporation (INCY)
1.57%
ACADIA Pharmaceuticals Inc. (ACAD)
1.54%
Clovis Oncology Inc. (CLVS)
1.53%
Madrigal Pharmaceuticals Inc. (MDGL)
1.51%
Ultragenyx Pharmaceutical Inc. (RARE)
1.5%
Puma Biotechnology Inc. (PBYI)
1.5%
Global Blood Therapeutics Inc (GBT)
1.49%
Neurocrine Biosciences Inc. (NBIX)
1.47%
Spark Therapeutics Inc. (ONCE)
1.47%
Alexion Pharmaceuticals Inc. (ALXN)
1.43%
Seattle Genetics Inc. (SGEN)
1.41%
Sarepta Therapeutics Inc. (SRPT)
1.4%
Arrowhead Pharmaceuticals Inc. (ARWR)
1.39%
Agios Pharmaceuticals Inc. (AGIO)
1.39%
Ionis Pharmaceuticals Inc. (IONS)
1.38%
United Therapeutics Corporation (UTHR)
1.37%
Vertex Pharmaceuticals Incorporated (VRTX)
1.36%
Regeneron Pharmaceuticals Inc. (REGN)
1.35%
Alnylam Pharmaceuticals Inc (ALNY)
1.34%
Amicus Therapeutics Inc. (FOLD)
1.33%
Exelixis Inc. (EXEL)
1.32%
Heron Therapeutics Inc (HRTX)
1.31%
Biogen Inc. (BIIB)
1.28%
Intercept Pharmaceuticals Inc. (ICPT)
1.28%
Blueprint Medicines Corp. (BPMC)
1.27%
REGENXBIO Inc. (RGNX)
1.26%
Gilead Sciences Inc. (GILD)
1.26%
Viking Therapeutics Inc. (VKTX)
1.25%
BioMarin Pharmaceutical Inc. (BMRN)
1.25%
AnaptysBio Inc. (ANAB)
1.24%
Myriad Genetics Inc. (MYGN)
1.23%
Alkermes Plc (ALKS)
1.23%
Arena Pharmaceuticals Inc. (ARNA)
1.22%
Enanta Pharmaceuticals Inc. (ENTA)
1.22%
Amgen Inc. (AMGN)
1.21%
AbbVie Inc. (ABBV)
1.17%
Insmed Incorporated (INSM)
1.16%
Esperion Therapeutics Inc. (ESPR)
1.15%
Genomic Health Inc. (GHDX)
1.15%
Repligen Corporation (RGEN)
1.11%
Emergent BioSolutions Inc. (EBS)
1.1%
Ligand Pharmaceuticals Incorporated (LGND)
1.1%
PTC Therapeutics Inc. (PTCT)
1.07%
Immunomedics Inc. (IMMU)
0.93%
Spectrum Pharmaceuticals Inc. (SPPI)
0.91%
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.9%
Sangamo Therapeutics Inc. (SGMO)
0.87%
Atara Biotherapeutics Inc (ATRA)
0.86%
Invitae Corp. (NVTA)
0.86%
Acceleron Pharma Inc (XLRN)
0.72%
ImmunoGen Inc. (IMGN)
0.71%
CareDx Inc. (CDNA)
0.71%
Halozyme Therapeutics Inc. (HALO)
0.67%
Aimmune Therapeutics Inc (AIMT)
0.65%
Radius Health Inc (RDUS)
0.64%
OPKO Health Inc. (OPK)
0.63%
Natera Inc. (NTRA)
0.62%
Editas Medicine Inc. (EDIT)
0.62%
Iovance Biotherapeutics Inc (IOVA)
0.61%
Cara Therapeutics Inc (CARA)
0.61%
Intrexon Corporation (XON)
0.61%
Coherus BioSciences Inc. (CHRS)
0.59%
Acorda Therapeutics Inc. (ACOR)
0.59%
Alder Biopharmaceuticals Inc. (ALDR)
0.58%
Vericel Corporation (VCEL)
0.57%
AMAG Pharmaceuticals Inc. (AMAG)
0.57%
Audentes Therapeutics Inc. (BOLD)
0.57%
Verastem Inc. (VSTM)
0.56%
Intellia Therapeutics Inc. (NTLA)
0.54%
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
0.53%
Eagle Pharmaceuticals Inc. (EGRX)
0.53%
Flexion Therapeutics Inc. (FLXN)
0.53%
Vanda Pharmaceuticals Inc. (VNDA)
0.5%
Epizyme Inc. (EPZM)
0.47%
Momenta Pharmaceuticals Inc. (MNTA)
0.47%
Dynavax Technologies Corporation (DVAX)
0.45%
Xencor Inc. (XNCR)
0.42%
G1 Therapeutics Inc. (GTHX)
0.41%
Novavax Inc. (NVAX)
0.39%
TG Therapeutics Inc. (TGTX)
0.36%
Progenics Pharmaceuticals Inc. (PGNX)
0.35%
Fate Therapeutics Inc. (FATE)
0.34%
Retrophin Inc. (RTRX)
0.33%
Karyopharm Therapeutics Inc. (KPTI)
0.33%
CytomX Therapeutics Inc. (CTMX)
0.32%
MacroGenics Inc. (MGNX)
0.31%
Deciphera Pharmaceuticals Inc. (DCPH)
0.3%
Dicerna Pharmaceuticals Inc. (DRNA)
0.3%
Denali Therapeutics Inc. (DNLI)
0.29%
Rigel Pharmaceuticals Inc. (RIGL)
0.25%
Prothena Corp. Plc (PRTA)
0.24%
Sorrento Therapeutics Inc. (SRNE)
0.23%
ArQule Inc. (ARQL)
0.21%
PDL BioPharma Inc. (PDLI)
0.18%
BioCryst Pharmaceuticals Inc. (BCRX)
0.18%
GlycoMimetics Inc. (GLYC)
0.18%
Five Prime Therapeutics Inc. (FPRX)
0.18%
Athenex Inc. (ATNX)
0.17%
Allakos Inc. (ALLK)
0.17%
Loxo Oncology Inc (LOXO)
0.17%
Rhythm Pharmaceuticals Inc. (RYTM)
0.17%
Inovio Pharmaceuticals Inc. (INO)
0.16%
ZIOPHARM Oncology Inc. (ZIOP)
0.16%
Akebia Therapeutics Inc. (AKBA)
0.15%
Stemline Therapeutics Inc. (STML)
0.14%
Achillion Pharmaceuticals Inc. (ACHN)
0.14%
Kura Oncology Inc. (KURA)
0.14%
Apellis Pharmaceuticals Inc. (APLS)
0.14%
Lexicon Pharmaceuticals Inc. (LXRX)
0.11%
Cytokinetics Incorporated (CYTK)
0.1%
Solid Biosciences Inc. (SLDB)
0.1%
STATE STREET INSTL US GOVERNME STIF USD (Unassigned)
0.09%
SPDR S & P Biotech ETF (XBI)
0%
U.S. Dollar
0%

XBI Technicals

Alpha

-8

Beta

1.65

Leverage

Long

Standard Deviation

8.58

XBI Dividends

Dividend Date

2018-12-21

Latest Dividend

0.012

Annual Dividend

0.2

Annual Dividend Rate

0.2

Annual Dividend Yield

0.24

XBI Performance

YTD Return

20.68%

1 Year Return

-6.62%

3 Year Return

72.77%

5 Year Return

58.02%

10 Year Return

461.3%

XBI Related Articles

Biotech ETFs Could See More Inflows

Biotech ETFs Could See More Inflows

After languishing in the latter stages of 2018, the iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech exchange traded fund…